Brickell Biotech, Inc. announced that on July 28, 2022, Dennison T. Veru informed of his resignation from the Company's Board of Directors, effective immediately. In submitting his resignation, Mr. Veru expressed that this decision is for personal reasons and that he is not resigning as a result of any disagreement on any matter relating to the operations, policies or practices of the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.91 USD | 0.00% | +1.11% | +3.51% |
Mar. 15 | Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
+3.51% | 5.44M | |
-0.22% | 103B | |
+3.45% | 96.73B | |
+1.66% | 21.31B | |
-16.16% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-23.01% | 13.68B | |
+6.80% | 13.44B | |
+22.36% | 10.98B |
- Stock Market
- Equities
- FRTX Stock
- News Fresh Tracks Therapeutics, Inc.
- Brickell Biotech, Inc. Announces Resignation of Dennison T. Veru from the Board of Directors